Pyxis Biologix is currently researching an exciting new product, Trisenoside™. Derived from compounds naturally occurring in ginseng, Trisenoside™ is well tolerated and has systemic beneficial effects.

Constituents of Trisenoside™ exhibit strong anti-carcinogenic and anti-angiogenic effects, inducing apoptosis and inhibiting growth in many types of cancer. Trisenoside™ also has synergistic effects with conventional cancer treatments such as chemotherapy, EGFR-TKI, recombinant human endostatin and low-dose metronomic temozolomide, increasing efficacy and decreasing adverse effects.

Trisenoside™ protects many organs from damage, including the liver, heart, brain and bones. It is also a potent anti-inflammatory and has synergistic activity with dexamethasone, a conventional anti-inflammatory treatment. Trisenoside™ also exhibits anti-depressant and anti-nociceptive properties, lowers hypertensive blood pressure and suppresses body fat weight gain.